Abemaciclib for metastatic breast cancer
19/08/2020
This quiz is based on the article Abemaciclib▼ for the treatment of hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2−) metastatic breast cancer (Cancer Nursing Practice, August 2020)
Gain a CPD certificate and add CPD time to your RCNi Portfolio.